Vol 11, No 3 (2017)
Review paper
Published online: 2017-12-21

open access

Page views 840
Article views/downloads 5550
Get Citation

Connect on Social Media

Connect on Social Media

The place of cannabinoids in the treatment of pain

Jarosław Woroń1, Jan Dobrogowski
Medycyna Paliatywna w Praktyce 2017;11(3):96-101.

Abstract

Cannabinoids represent another therapeutic option in patients with pain. Their legal availability for Polish patients causes acute pain doctors try to gather the most up-to-date information on the location of these drugs in the treatment of pain. The paper fulfills these expectations.

Article available in PDF format

View PDF (Polish) Download PDF file

References

  1. Parker L. Cannabinoids and the Brain. The MIT Press. 2017.
  2. Maida V, Daeninck PJ. A user's guide to cannabinoid therapies in oncology. Curr Oncol. 2016; 23(6): 398–406.
  3. Schrot RJ, Hubbard JR. Cannabinoids: Medical implications. Ann Med. 2016; 48(3): 128–141.
  4. Young RJ, Nguyen M, Nelson E. Pain Medicine Springer, Switzerland 2017.
  5. Carroll CB, Bain PG, Teare L, et al. Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study. Neurology. 2004; 63(7): 1245–1250.
  6. Gancher ST. The Unified Parkinson’s Disease Rating Scale. Portland, OR: Demos Medical Publishing 2002.
  7. Sieradzan KA, Fox SH, Hill M, et al. Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study. Neurology. 2001; 57(11): 2108–2111.
  8. Müller-Vahl KR, Schneider U, Koblenz A, et al. Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial. Pharmacopsychiatry. 2002; 35(2): 57–61.
  9. Müller-Vahl KR, Schneider U, Prevedel H, et al. Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial. J Clin Psychiatry. 2003; 64(4): 459–465.
  10. Koppel BS, Brust JCM, Fife T, et al. Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2014; 82(17): 1556–1563.
  11. Ko GD, Bober SL, Mindra S, et al. Medical cannabis - the Canadian perspective. J Pain Res. 2016; 9: 735–744.
  12. Abrams D. Integrating Cannabis Into Clinical Care. Current Oncology . 2016; Suppl 2: 23.
  13. Kramer JL. Medical marijuana for cancer. CA Cancer J Clin. 2015; 65(2): 109–122.